Clinical Trials in Los Angeles

Showing 4441-4460 of 12,794 trials

Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors

NCT03382834

This study evaluated the effects of tamoxifen exposure in combination with vorinostat on viral reactivation among HIV-1 infected post-menopausal women with virologic suppression on antiretroviral therapy (ART), when compared to vorinostat alone.

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)31 participantsStarted Apr 2018

Birmingham, Alabama, United States • Los Angeles, California, United States • San Francisco, California, United States +12 more locations

TERMINATEDPhase 2< 1 mile

An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease

NCT03599622

The purpose of this study is to assess the safety and effectiveness of BMS-986165 compared to placebo in participants with moderately to severely active Crohn's Disease.

Granulomatous ColitisCrohn's DiseaseCrohn's Enteritis+1 more

Bristol-Myers Squibb239 participantsStarted Jul 2018

Los Angeles, California, United States • Aurora, Colorado, United States • Hamden, Connecticut, United States +256 more locations

Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors

An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease

Find Trials by Condition in Los Angeles

A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease

A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

TRC-PAD Program: In-Clinic Trial-Ready Cohort

Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant

Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer

Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT®

A Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia

Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma

Pegloticase and Methotrexate Co-administered in Participants With Uncontrolled Gout Who Previously Failed Pegloticase Monotherapy

Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma

Plant-Focused Nutrition in Patients With Diabetes and Chronic Kidney Disease

Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata

The COAT Trial: Cequa's Onset of Action Trial

Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex

Psychotherapy for PTSD Among Veterans Also Receiving Drug or Alcohol Treatment

The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia

Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout

A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer